About Enzon
Technology Platforms
Research & Development
Marketed Products
Partnering
Newsroom
Investors
Careers
Contact Us
Home
>
Investors
Analyst Coverage
Annual Reports
Press Releases
SEC Filings
Request Information
Calendar of Events
E-mail Alerts
Stock Quote
Stock Lookup
Corporate Governance
Contact Us
Printed Materials
Print page
Email page
To receive printed material by postal mail, please complete the following form.
*
Fields are Required
Please send me
*
Document
Request
View Online
Proxy Statement
N/A
Investor Kit (includes recent press releases)
N/A
Form 10-Q
N/A
Form 10-K
N/A
First name
*
Last name
*
Email
*
Title
Company
Profile
*
Please Select
Shareholder
Analyst
Media
Employee
Other
Address
*
City
*
State/province
*
Postal code
*
Country
*
Shipment method
Postal Mail
DHL
Federal Express
Federal Express Priority
UPS Next Day Air
Account number
Required for express delivery
Telephone
Home
Fax
Work
Extension
I am interested in receiving investor relations notifications. **
** An email will be sent to your email address confirming your identity. You will then be given options to sign up for webcast and other alerts.
Stock Information
(ENZN) NASD
Last Trade
9.350
Change(%)
+ 0.03
Volume
128,200
May 9, 2008 12:44 PM ET
New Product Release
Our four proprietary marketed brands are ABELCET
®
, ADAGEN
®
, DEPOCYT
®
, and ONCASPAR
®
. To learn more about our recent product releases
CLICK HERE
Shareholder Tools
Shareholder Briefcase
Printed Materials
Email Alerts
Download Library
Glossary
RSS News Feeds
Search Investor Relations
Investor site
Section only